SI2846805T1 - Zdravljenje zasvojenosti in motenj v obvladovanju impulzov z uporabo inhibitorjev PDE7 - Google Patents

Zdravljenje zasvojenosti in motenj v obvladovanju impulzov z uporabo inhibitorjev PDE7

Info

Publication number
SI2846805T1
SI2846805T1 SI201331354T SI201331354T SI2846805T1 SI 2846805 T1 SI2846805 T1 SI 2846805T1 SI 201331354 T SI201331354 T SI 201331354T SI 201331354 T SI201331354 T SI 201331354T SI 2846805 T1 SI2846805 T1 SI 2846805T1
Authority
SI
Slovenia
Prior art keywords
addiction
impulse
treatment
control disorders
pde7 inhibitors
Prior art date
Application number
SI201331354T
Other languages
English (en)
Slovenian (sl)
Inventor
Gregory A. Demopulos
George A. Gaitanaris
Roberto Ciccocioppo
Original Assignee
Omeros Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/835,607 external-priority patent/US9220715B2/en
Application filed by Omeros Corporation filed Critical Omeros Corporation
Publication of SI2846805T1 publication Critical patent/SI2846805T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI201331354T 2012-05-07 2013-05-07 Zdravljenje zasvojenosti in motenj v obvladovanju impulzov z uporabo inhibitorjev PDE7 SI2846805T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261643611P 2012-05-07 2012-05-07
US13/835,607 US9220715B2 (en) 2010-11-08 2013-03-15 Treatment of addiction and impulse-control disorders using PDE7 inhibitors
PCT/US2013/039866 WO2013176877A2 (en) 2012-05-07 2013-05-07 Treatment of addiction and impulse-control disorders using pde7 inhibitors
EP13793319.8A EP2846805B1 (en) 2012-05-07 2013-05-07 Treatment of addiction and impulse-control disorders using pde7 inhibitors

Publications (1)

Publication Number Publication Date
SI2846805T1 true SI2846805T1 (sl) 2019-04-30

Family

ID=49624481

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201331354T SI2846805T1 (sl) 2012-05-07 2013-05-07 Zdravljenje zasvojenosti in motenj v obvladovanju impulzov z uporabo inhibitorjev PDE7

Country Status (10)

Country Link
EP (1) EP2846805B1 (enExample)
JP (1) JP2015521177A (enExample)
CN (3) CN112168972A (enExample)
AU (1) AU2013266793B2 (enExample)
CA (1) CA2871151C (enExample)
IN (1) IN2014DN10404A (enExample)
PL (1) PL2846805T3 (enExample)
RS (1) RS58381B1 (enExample)
SI (1) SI2846805T1 (enExample)
WO (1) WO2013176877A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9220715B2 (en) 2010-11-08 2015-12-29 Omeros Corporation Treatment of addiction and impulse-control disorders using PDE7 inhibitors
KR20130124333A (ko) 2010-11-08 2013-11-13 오메로스 코포레이션 Pde7 억제제를 사용한 중독 및 충동-조절 장애의 치료
RU2019108464A (ru) 2016-08-26 2020-09-28 Мицубиси Танабе Фарма Корпорейшн Бициклическое азотсодержащее гетероциклическое соединение
EP4541372A1 (en) * 2022-06-15 2025-04-23 Shinichi Matsumoto Drug therapy for obsessive-compulsive disorder targeting dopamine d1 signal in striatal striosomes
AU2023326563A1 (en) * 2022-08-18 2025-02-27 Mitodicure Gmbh Use of a therapeutic agent with phosphodiesterase-7 inhibitory activity for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2433943B1 (en) * 2004-07-01 2013-09-11 Daiichi Sankyo Company, Limited Intermediates for thienopyrazole derivatives having PDE7 inhibitory activity
US20060183763A1 (en) * 2004-12-31 2006-08-17 Pfizer Inc Novel pyrrolidyl derivatives of heteroaromatic compounds
PT1928438E (pt) * 2005-09-26 2013-04-03 Avigen Inc Método para tratamento de dependências de drogas e comportamentos
WO2008119057A2 (en) * 2007-03-27 2008-10-02 Omeros Corporation The use of pde7 inhibitors for the treatment of movement disorders
US8637528B2 (en) * 2007-03-27 2014-01-28 Omeros Corporation Use of PDE7 inhibitors for the treatment of movement disorders
US8426439B2 (en) * 2007-04-11 2013-04-23 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
FR2943673B1 (fr) * 2009-03-27 2013-03-29 Sanofi Aventis Applications therapeutiques de derives de quinazolinedione
FR2944282B1 (fr) * 2009-04-09 2013-05-03 Sanofi Aventis Derives de quinazolinedione, leur preparation et leurs diverses applications therapeutiques
KR20130124333A (ko) * 2010-11-08 2013-11-13 오메로스 코포레이션 Pde7 억제제를 사용한 중독 및 충동-조절 장애의 치료

Also Published As

Publication number Publication date
WO2013176877A3 (en) 2015-06-18
RS58381B1 (sr) 2019-04-30
EP2846805A2 (en) 2015-03-18
EP2846805B1 (en) 2018-11-21
WO2013176877A2 (en) 2013-11-28
JP2015521177A (ja) 2015-07-27
CN114984229A (zh) 2022-09-02
AU2013266793A1 (en) 2014-11-27
EP2846805A4 (en) 2016-08-10
AU2013266793B2 (en) 2016-08-04
IN2014DN10404A (enExample) 2015-08-14
CN104768556A (zh) 2015-07-08
CA2871151C (en) 2019-03-26
CN112168972A (zh) 2021-01-05
PL2846805T3 (pl) 2019-05-31
CA2871151A1 (en) 2013-11-28

Similar Documents

Publication Publication Date Title
IL261768B (en) Devices and methods for tissue treatment
ZA202108991B (en) Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms
GB2498121B (en) Treatment device and method of use
EP2887805A4 (en) COMPOUNDS AND METHOD FOR TREATING BLOOD HIGH PRESSURE
PL2825161T3 (pl) Inhibitory ludzkiej ezh2 i sposoby ich zastosowania
IL226203A0 (en) Use of pde7 suppressors and preparations containing them for the treatment of sales and disorders
SG11201504022RA (en) Glutamase inhibitors and method of use
IL237528B (en) Methods for preventing and treating preeclampsia
SMT201700451T1 (it) Antagonisti di wnt e metodi di trattamento
ZA201408055B (en) Compositions and methods for the treatment of local pain
GB201217296D0 (en) Method of treatment and/or prevention
IL232135A0 (en) Therapeutic combinations and methods for treating melanoma
LT2827883T (lt) Tfpi inhibitoriai ir jų panaudojimo būdai
ZA201607980B (en) Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms
ZA201501503B (en) Bio-inoculant and use thereof for treatment of effluents
IL237887A0 (en) Devices and methods for encouraging hair growth
HRP20181761T1 (hr) Novi pripravak alfentanila za liječenje akutne boli
PL2846805T3 (pl) Leczenie uzależnień i zaburzeń kontroli impulsów za pomocą inhibitorów PDE7
LT2846805T (lt) Priklausomybių ir impulsų kontrolės sutrikimų gydymas, panaudojant pde7 inhibitorius
EP2640468A4 (en) ADMINISTRATIVE AND TREATMENT PROCEDURES
HK1189511A (en) Treatment of addiction and impulse-control disorders using pde7 inhibitors
GB201101688D0 (en) Treatment of porous structire and device therefor
ZA201501068B (en) Methods for prevention and treatment of preeclampsia
GB201206330D0 (en) Methods of treatment